Hepta Bio

San Francisco, United States

Hepta Bio detect, monitor, and direct the most effective liver treatment.

$6.7M raised

Nov 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Hepta Bio raised?

Hepta Bio has raised $6.7M in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are Hepta Bio's investors?

Hepta Bio's investors include Alumni Ventures, Felicis, Illumina Ventures, SeaX Ventures, AME Cloud Ventures.

Where is Hepta Bio headquartered?

Hepta Bio is headquartered in San Francisco, United States.

What does Hepta Bio do?

Hepta Bio detect, monitor, and direct the most effective liver treatment.

What stage is Hepta Bio at?

Hepta Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 5, 2025.

MLA

"Hepta Bio — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/hepta-bio. Accessed July 9, 2026.

APA

VCBacked. (2025). Hepta Bio — Funding & Investors. Retrieved July 9, 2026, from https://www.vcbacked.co/company/hepta-bio

Wikipedia (cite web)

{{cite web |title=Hepta Bio — Funding & Investors |url=https://www.vcbacked.co/company/hepta-bio |website=VCBacked |access-date=July 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 5, 2025.